{"id":16039,"date":"2021-04-13T09:19:02","date_gmt":"2021-04-13T09:19:02","guid":{"rendered":"https:\/\/www.neuraxpharm.com\/it2\/?page_id=16039"},"modified":"2025-12-29T09:03:24","modified_gmt":"2025-12-29T09:03:24","slug":"ana-apezteguia","status":"publish","type":"page","link":"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif\/ana-apezteguia","title":{"rendered":"ANA APEZTEGUIA"},"content":{"rendered":"\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
\n\t\t\t<\/i>\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

https:\/\/www.linkedin.com\/in\/ana-apezteguia-moragas\/<\/a><\/p>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t

\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t
\n\t\t
\n\t\t
Neuraxpharm<\/a><\/div>\n\t\t<\/div>\n\t\t<\/div>\n\t\t<\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

ANA APEZTEGUIA<\/h1>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Ana a plus de huit ans d\u2019exp\u00e9rience en strat\u00e9gie commerciale et en gestion de projets au sein de l\u2019industrie pharmaceutique.<\/p>

Elle a d\u2019abord rejoint Neuraxpharm en tant qu\u2019Associ\u00e9e de strat\u00e9gie aupr\u00e8s du PDG. Elle a ensuite \u00e9volu\u00e9 au poste de Directrice de cabinet, puis r\u00e9cemment au poste de Directrice de la strat\u00e9gie et de la transformation, ayant jou\u00e9 un r\u00f4le cl\u00e9 dans l\u2019int\u00e9gration r\u00e9ussie des diff\u00e9rents march\u00e9s du groupe \u00e0 travers plusieurs pays. Ana est responsable du d\u00e9partement de strat\u00e9gie, du portefeuille, de la gestion de projets et de lancements, de la communication externe, de l\u2019ESG et des technologies num\u00e9riques.<\/p>

Elle a d\u00e9velopp\u00e9 sa carri\u00e8re professionnelle en tant que consultante en d\u00e9veloppent commercial et strat\u00e9gie chez Capgemini Invent (anciennement Capgemini Consulting), travaillant principalement sur des projets dans l\u2019industrie pharmaceutique.<\/p>

Ana est titulaire d\u2019une licence en g\u00e9nie industriel de l\u2019Universitat Polit\u00e8cnica de Catalunya (UPC), avec une sp\u00e9cialisation en gestion et organisation industrielle, et elle est \u00e9galement dipl\u00f4m\u00e9e en strat\u00e9gie de l\u2019\u00c9cole nationale sup\u00e9rieure de techniques avanc\u00e9es (ENSTA) \u00e0 Paris.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

https:\/\/www.linkedin.com\/in\/ana-apezteguia-moragas\/ Neuraxpharm ANA APEZTEGUIA Ana a plus de huit ans d\u2019exp\u00e9rience en strat\u00e9gie commerciale et en gestion de projets au sein de l\u2019industrie pharmaceutique. Elle a d\u2019abord rejoint Neuraxpharm en tant qu\u2019Associ\u00e9e de strat\u00e9gie aupr\u00e8s du PDG. Elle a ensuite \u00e9volu\u00e9 au poste de Directrice de cabinet, puis r\u00e9cemment au poste de Directrice de la […]<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":1998,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"elementor_header_footer","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-16039","page","type-page","status-publish","hentry"],"yoast_head":"\nANA APEZTEGUIA - Neuraxpharm Switzerland<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif\/ana-apezteguia\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ANA APEZTEGUIA\" \/>\n<meta property=\"og:description\" content=\"https:\/\/www.linkedin.com\/in\/ana-apezteguia-moragas\/ Neuraxpharm ANA APEZTEGUIA Ana a plus de huit ans d\u2019exp\u00e9rience en strat\u00e9gie commerciale et en gestion de projets au sein de l\u2019industrie pharmaceutique. Elle a d\u2019abord rejoint Neuraxpharm en tant qu\u2019Associ\u00e9e de strat\u00e9gie aupr\u00e8s du PDG. Elle a ensuite \u00e9volu\u00e9 au poste de Directrice de cabinet, puis r\u00e9cemment au poste de Directrice de la […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif\/ana-apezteguia\" \/>\n<meta property=\"og:site_name\" content=\"Neuraxpharm Switzerland\" \/>\n<meta property=\"article:modified_time\" content=\"2025-12-29T09:03:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.neuraxpharm.com\/ch-fr\/wp-content\/uploads\/sites\/16\/2023\/03\/ana-apezteguia.jpg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif\/ana-apezteguia\",\"url\":\"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif\/ana-apezteguia\",\"name\":\"ANA APEZTEGUIA - Neuraxpharm Switzerland\",\"isPartOf\":{\"@id\":\"https:\/\/www.neuraxpharm.com\/ch-fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif\/ana-apezteguia#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif\/ana-apezteguia#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.neuraxpharm.com\/ch-fr\/wp-content\/uploads\/sites\/16\/2023\/03\/ana-apezteguia.jpg\",\"datePublished\":\"2021-04-13T09:19:02+00:00\",\"dateModified\":\"2025-12-29T09:03:24+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif\/ana-apezteguia#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif\/ana-apezteguia\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif\/ana-apezteguia#primaryimage\",\"url\":\"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/16\/2023\/03\/27093937\/ana-apezteguia.jpg\",\"contentUrl\":\"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/16\/2023\/03\/27093937\/ana-apezteguia.jpg\",\"width\":716,\"height\":700},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif\/ana-apezteguia#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"\u00c0 propos de nous\",\"item\":\"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Comit\u00e9 Ex\u00e9cutif\",\"item\":\"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"ANA APEZTEGUIA\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.neuraxpharm.com\/ch-fr\/#website\",\"url\":\"https:\/\/www.neuraxpharm.com\/ch-fr\/\",\"name\":\"Neuraxpharm Switzerland\",\"description\":\"Ein europ\u00e4ischer Marktf\u00fchrer f\u00fcr CNS-Produkte\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.neuraxpharm.com\/ch-fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"ANA APEZTEGUIA - Neuraxpharm Switzerland","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif\/ana-apezteguia","og_locale":"fr_FR","og_type":"article","og_title":"ANA APEZTEGUIA","og_description":"https:\/\/www.linkedin.com\/in\/ana-apezteguia-moragas\/ Neuraxpharm ANA APEZTEGUIA Ana a plus de huit ans d\u2019exp\u00e9rience en strat\u00e9gie commerciale et en gestion de projets au sein de l\u2019industrie pharmaceutique. Elle a d\u2019abord rejoint Neuraxpharm en tant qu\u2019Associ\u00e9e de strat\u00e9gie aupr\u00e8s du PDG. Elle a ensuite \u00e9volu\u00e9 au poste de Directrice de cabinet, puis r\u00e9cemment au poste de Directrice de la […]","og_url":"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif\/ana-apezteguia","og_site_name":"Neuraxpharm Switzerland","article_modified_time":"2025-12-29T09:03:24+00:00","og_image":[{"url":"https:\/\/www.neuraxpharm.com\/ch-fr\/wp-content\/uploads\/sites\/16\/2023\/03\/ana-apezteguia.jpg","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif\/ana-apezteguia","url":"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif\/ana-apezteguia","name":"ANA APEZTEGUIA - Neuraxpharm Switzerland","isPartOf":{"@id":"https:\/\/www.neuraxpharm.com\/ch-fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif\/ana-apezteguia#primaryimage"},"image":{"@id":"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif\/ana-apezteguia#primaryimage"},"thumbnailUrl":"https:\/\/www.neuraxpharm.com\/ch-fr\/wp-content\/uploads\/sites\/16\/2023\/03\/ana-apezteguia.jpg","datePublished":"2021-04-13T09:19:02+00:00","dateModified":"2025-12-29T09:03:24+00:00","breadcrumb":{"@id":"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif\/ana-apezteguia#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif\/ana-apezteguia"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif\/ana-apezteguia#primaryimage","url":"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/16\/2023\/03\/27093937\/ana-apezteguia.jpg","contentUrl":"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/16\/2023\/03\/27093937\/ana-apezteguia.jpg","width":716,"height":700},{"@type":"BreadcrumbList","@id":"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif\/ana-apezteguia#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"\u00c0 propos de nous","item":"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous"},{"@type":"ListItem","position":2,"name":"Comit\u00e9 Ex\u00e9cutif","item":"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif"},{"@type":"ListItem","position":3,"name":"ANA APEZTEGUIA"}]},{"@type":"WebSite","@id":"https:\/\/www.neuraxpharm.com\/ch-fr\/#website","url":"https:\/\/www.neuraxpharm.com\/ch-fr\/","name":"Neuraxpharm Switzerland","description":"Ein europ\u00e4ischer Marktf\u00fchrer f\u00fcr CNS-Produkte","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.neuraxpharm.com\/ch-fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"}]}},"acf":[],"_links":{"self":[{"href":"https:\/\/www.neuraxpharm.com\/ch-fr\/wp-json\/wp\/v2\/pages\/16039","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.neuraxpharm.com\/ch-fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.neuraxpharm.com\/ch-fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/ch-fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/ch-fr\/wp-json\/wp\/v2\/comments?post=16039"}],"version-history":[{"count":42,"href":"https:\/\/www.neuraxpharm.com\/ch-fr\/wp-json\/wp\/v2\/pages\/16039\/revisions"}],"predecessor-version":[{"id":27345,"href":"https:\/\/www.neuraxpharm.com\/ch-fr\/wp-json\/wp\/v2\/pages\/16039\/revisions\/27345"}],"up":[{"embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/ch-fr\/wp-json\/wp\/v2\/pages\/1998"}],"wp:attachment":[{"href":"https:\/\/www.neuraxpharm.com\/ch-fr\/wp-json\/wp\/v2\/media?parent=16039"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}